Journal
EMERGING MICROBES & INFECTIONS
Volume 11, Issue 1, Pages 616-628Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/22221751.2022.2037393
Keywords
MiRNA profile; miR-192-3p; hepatitis B virus; ZNF143; Akt; mTOR signalling; Abbreviations; CMIA; chemiluminescent microparticle immunoassay; HBV; hepatitis B virus; HSC; hepatic stellate cell; KC; Kupffer cell; LSEC; liver sinusoidal endothelial cell; pgRNA; pregenomic RNA; PHH; primary human hepatocyte; RI; replicative intermediate
Categories
Funding
- National Natural Science Foundation of China [81871640, 82172255, 81800526, 82002131, 81801999]
- Shanghai Shen Kang Hospital Development Center [SHDC12019116]
- Shanghai Key Clinical Specialty Construction Program [ZK2019B24]
- Shang Rao Science and Technology Department [2020D001]
- Medizinische Fakultat Universitat Duisburg Essen
Ask authors/readers for more resources
In this study, the specific miRNA profiles enriched in different hepatic cell types were identified. The miRNA miR-192-3p was found to have the greatest pro-virus effect in primary human hepatocytes, and its promotion of HBV replication was mediated through the inhibition of Akt/mTOR signaling by directly targeting ZNF143. These findings highlight the importance of hepatic cell type-enriched miRNA in regulating HBV replication and contribute to our understanding of liver pathogenesis.
Previous studies have revealed multiple tissue- or cell-specific or enriched miRNA profiles. However, miRNA profiles enriched in hepatic cell types and their effect on HBV replication have not been well elucidated. In this study, primary human hepatocytes (PHHs), Kupffer cells (KCs), liver sinusoidal endothelial cells (LSECs), and hepatic stellate cells (HSCs) were prepared from liver specimens of non-HBV-infected patients. Four hepatic cell type-enriched miRNA profiles were identified from purified liver cells miRNA microarray assay. The results revealed that 12 miRNAs, including miR-122-5p and miR-192-3p were PHH-enriched; 9 miRNAs, including miR-142-5p and miR-155-5p were KC-enriched; 6 miRNAs, including miR-126-3p and miR-222-3p were LSEC-enriched; and 14 miRNAs, including miR-214-3p and miR-199a-3p were HSC-enriched. By testing the effect of 11 PHH-enriched miRNAs on HBV production, we observed that miR-192-3p had the greatest pro-virus effect in hepatic cell lines. Moreover, we further found that miR-192-3p promoted HBV replication and gene expression through inhibiting Akt/mTOR signalling by direct targeting of ZNF143 in HepG2.2.15 cells. Additionally, the serum and hepatic miR-192-3p expression levels were significantly higher in chronic hepatitis B patients than in healthy controls and serum miR-192-3p positively correlated with the serum levels of HBV DNA and HBsAg. Collectively, we identified miRNA profiles enriched in four hepatic cell types and revealed that PHH-enriched miR-192-3p promoted HBV replication through inhibiting Akt/mTOR signalling by direct targeting of ZNF143 in hepatic cell lines. Our study provides a specific perspective for the role of hepatic cell type-enriched miRNA in interaction with viral replication and various liver pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available